0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Codeine Market Research Report 2026
Published Date: 2026-02-26
|
Report Code: QYRE-Auto-18I9054
Home | Market Reports
Global Codeine Market Outlook 2022
BUY CHAPTERS

Global Codeine Market Research Report 2026

Code: QYRE-Auto-18I9054
Report
2026-02-26
Pages:121
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Codeine Market Size

The global Codeine market was valued at US$ 232 million in 2025 and is anticipated to reach US$ 157 million by 2032, at a CAGR of -5.5% from 2026 to 2032.

Codeine Market

Codeine Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Codeine competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Codeine is an opiate used to treat pain, coughing, and diarrhea. It is typically used to treat mild to moderate degrees of pain.
Market competition is intense. Taiji, Mallinckrodt, TEVA, Johnson & Johnson, Medreich, Sanofi Aventis, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers. For the major company of Codeine, Taiji and Mallinckrodt accounted for about 16% market share respectively in recent years.
This report delivers a comprehensive overview of the global Codeine market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Codeine. The Codeine market size, estimates, and forecasts are provided in terms of sales volume (M Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Codeine market comprehensively. Regional market sizes by Ingredient, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Codeine manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Ingredient, by Application, and by region.
Market Segmentation

Scope of Codeine Market Report

Report Metric Details
Report Name Codeine Market
Accounted market size in 2025 US$ 232 million
Forecasted market size in 2032 US$ 157 million
Base Year 2025
Forecasted years 2026 - 2032
Segment by Ingredient
  • Single-ingredient Codeine
  • Multi-ingredient Medications
by Application
  • Narcotic Analgesic
  • Antitussive
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Taiji, Mallinckrodt, TEVA, Johnson & Johnson, Medreich, Sanofi Aventis, Cipla, Hikma, Pharmaceutical Associates, Novartis, Apotex, Mylan, Aristo Pharma GmbH, Lannett Company, Laboratoire Riva
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Ingredient, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Codeine manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Codeine sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Ingredient, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

What is the Codeine Market size in 2032?

Ans: The Codeine Market size in 2032 will be US$ 157 million.

What is the Taiji, Mallinckrodt share in Codeine Market?

Ans: For the major company of Codeine, Taiji and Mallinckrodt accounted for about 16% market share respectively in recent years.

Who are the main players in the Codeine Market report?

Ans: The main players in the Codeine Market are Taiji, Mallinckrodt, TEVA, Johnson & Johnson, Medreich, Sanofi Aventis, Cipla, Hikma, Pharmaceutical Associates, Novartis, Apotex, Mylan, Aristo Pharma GmbH, Lannett Company, Laboratoire Riva

What are the Application segmentation covered in the Codeine Market report?

Ans: The Applications covered in the Codeine Market report are Narcotic Analgesic, Antitussive, Others

1 Codeine Market Overview
1.1 Product Definition
1.2 Codeine by Ingredient
1.2.1 Global Codeine Market Value by Ingredient: 2025 vs 2032
1.2.2 Single-ingredient Codeine
1.2.3 Multi-ingredient Medications
1.3 Codeine by Application
1.3.1 Global Codeine Market Value by Application: 2025 vs 2032
1.3.2 Narcotic Analgesic
1.3.3 Antitussive
1.3.4 Others
1.4 Global Codeine Market Size Estimates and Forecasts
1.4.1 Global Codeine Revenue 2021–2032
1.4.2 Global Codeine Sales 2021–2032
1.4.3 Global Codeine Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Codeine Market Competition by Manufacturers
2.1 Global Codeine Sales Market Share by Manufacturers (2021–2026)
2.2 Global Codeine Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Codeine Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Codeine, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Codeine, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Codeine, Product Types and Applications
2.7 Global Key Manufacturers of Codeine, Date of Entry into the Industry
2.8 Global Codeine Market Competitive Situation and Trends
2.8.1 Global Codeine Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Codeine Players Market Share by Revenue
2.8.3 Global Codeine Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Codeine Market Scenario by Region
3.1 Global Codeine Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Codeine Sales by Region: 2021–2032
3.2.1 Global Codeine Sales by Region: 2021–2026
3.2.2 Global Codeine Sales by Region: 2027–2032
3.3 Global Codeine Revenue by Region: 2021–2032
3.3.1 Global Codeine Revenue by Region: 2021–2026
3.3.2 Global Codeine Revenue by Region: 2027–2032
3.4 North America Codeine Market Facts & Figures by Country
3.4.1 North America Codeine Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Codeine Sales by Country (2021–2032)
3.4.3 North America Codeine Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Codeine Market Facts & Figures by Country
3.5.1 Europe Codeine Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Codeine Sales by Country (2021–2032)
3.5.3 Europe Codeine Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Codeine Market Facts & Figures by Region
3.6.1 Asia Pacific Codeine Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Codeine Sales by Region (2021–2032)
3.6.3 Asia Pacific Codeine Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Codeine Market Facts & Figures by Country
3.7.1 Latin America Codeine Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Codeine Sales by Country (2021–2032)
3.7.3 Latin America Codeine Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Codeine Market Facts & Figures by Country
3.8.1 Middle East and Africa Codeine Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Codeine Sales by Country (2021–2032)
3.8.3 Middle East and Africa Codeine Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Ingredient
4.1 Global Codeine Sales by Ingredient (2021–2032)
4.1.1 Global Codeine Sales by Ingredient (2021–2026)
4.1.2 Global Codeine Sales by Ingredient (2027–2032)
4.1.3 Global Codeine Sales Market Share by Ingredient (2021–2032)
4.2 Global Codeine Revenue by Ingredient (2021–2032)
4.2.1 Global Codeine Revenue by Ingredient (2021–2026)
4.2.2 Global Codeine Revenue by Ingredient (2027–2032)
4.2.3 Global Codeine Revenue Market Share by Ingredient (2021–2032)
4.3 Global Codeine Price by Ingredient (2021–2032)
5 Segment by Application
5.1 Global Codeine Sales by Application (2021–2032)
5.1.1 Global Codeine Sales by Application (2021–2026)
5.1.2 Global Codeine Sales by Application (2027–2032)
5.1.3 Global Codeine Sales Market Share by Application (2021–2032)
5.2 Global Codeine Revenue by Application (2021–2032)
5.2.1 Global Codeine Revenue by Application (2021–2026)
5.2.2 Global Codeine Revenue by Application (2027–2032)
5.2.3 Global Codeine Revenue Market Share by Application (2021–2032)
5.3 Global Codeine Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Taiji
6.1.1 Taiji Company Information
6.1.2 Taiji Description and Business Overview
6.1.3 Taiji Codeine Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Taiji Codeine Product Portfolio
6.1.5 Taiji Recent Developments/Updates
6.2 Mallinckrodt
6.2.1 Mallinckrodt Company Information
6.2.2 Mallinckrodt Description and Business Overview
6.2.3 Mallinckrodt Codeine Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Mallinckrodt Codeine Product Portfolio
6.2.5 Mallinckrodt Recent Developments/Updates
6.3 TEVA
6.3.1 TEVA Company Information
6.3.2 TEVA Description and Business Overview
6.3.3 TEVA Codeine Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 TEVA Codeine Product Portfolio
6.3.5 TEVA Recent Developments/Updates
6.4 Johnson & Johnson
6.4.1 Johnson & Johnson Company Information
6.4.2 Johnson & Johnson Description and Business Overview
6.4.3 Johnson & Johnson Codeine Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Johnson & Johnson Codeine Product Portfolio
6.4.5 Johnson & Johnson Recent Developments/Updates
6.5 Medreich
6.5.1 Medreich Company Information
6.5.2 Medreich Description and Business Overview
6.5.3 Medreich Codeine Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Medreich Codeine Product Portfolio
6.5.5 Medreich Recent Developments/Updates
6.6 Sanofi Aventis
6.6.1 Sanofi Aventis Company Information
6.6.2 Sanofi Aventis Description and Business Overview
6.6.3 Sanofi Aventis Codeine Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Sanofi Aventis Codeine Product Portfolio
6.6.5 Sanofi Aventis Recent Developments/Updates
6.7 Cipla
6.7.1 Cipla Company Information
6.7.2 Cipla Description and Business Overview
6.7.3 Cipla Codeine Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Cipla Codeine Product Portfolio
6.7.5 Cipla Recent Developments/Updates
6.8 Hikma
6.8.1 Hikma Company Information
6.8.2 Hikma Description and Business Overview
6.8.3 Hikma Codeine Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Hikma Codeine Product Portfolio
6.8.5 Hikma Recent Developments/Updates
6.9 Pharmaceutical Associates
6.9.1 Pharmaceutical Associates Company Information
6.9.2 Pharmaceutical Associates Description and Business Overview
6.9.3 Pharmaceutical Associates Codeine Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Pharmaceutical Associates Codeine Product Portfolio
6.9.5 Pharmaceutical Associates Recent Developments/Updates
6.10 Novartis
6.10.1 Novartis Company Information
6.10.2 Novartis Description and Business Overview
6.10.3 Novartis Codeine Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Novartis Codeine Product Portfolio
6.10.5 Novartis Recent Developments/Updates
6.11 Apotex
6.11.1 Apotex Company Information
6.11.2 Apotex Description and Business Overview
6.11.3 Apotex Codeine Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Apotex Codeine Product Portfolio
6.11.5 Apotex Recent Developments/Updates
6.12 Mylan
6.12.1 Mylan Company Information
6.12.2 Mylan Description and Business Overview
6.12.3 Mylan Codeine Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Mylan Codeine Product Portfolio
6.12.5 Mylan Recent Developments/Updates
6.13 Aristo Pharma GmbH
6.13.1 Aristo Pharma GmbH Company Information
6.13.2 Aristo Pharma GmbH Description and Business Overview
6.13.3 Aristo Pharma GmbH Codeine Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Aristo Pharma GmbH Codeine Product Portfolio
6.13.5 Aristo Pharma GmbH Recent Developments/Updates
6.14 Lannett Company
6.14.1 Lannett Company Company Information
6.14.2 Lannett Company Description and Business Overview
6.14.3 Lannett Company Codeine Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Lannett Company Codeine Product Portfolio
6.14.5 Lannett Company Recent Developments/Updates
6.15 Laboratoire Riva
6.15.1 Laboratoire Riva Company Information
6.15.2 Laboratoire Riva Description and Business Overview
6.15.3 Laboratoire Riva Codeine Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Laboratoire Riva Codeine Product Portfolio
6.15.5 Laboratoire Riva Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Codeine Industry Chain Analysis
7.2 Codeine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Codeine Production Mode & Process Analysis
7.4 Codeine Sales and Marketing
7.4.1 Codeine Sales Channels
7.4.2 Codeine Distributors
7.5 Codeine Customer Analysis
8 Codeine Market Dynamics
8.1 Codeine Industry Trends
8.2 Codeine Market Drivers
8.3 Codeine Market Challenges
8.4 Codeine Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Codeine Market Value by Ingredient (US$ Million), 2025 vs 2032
 Table 2. Global Codeine Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Codeine Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Codeine Sales (M Units) of Key Manufacturers (2021–2026)
 Table 5. Global Codeine Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Codeine Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Codeine Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Codeine Average Price (USD/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Codeine, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Codeine, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Codeine, Product Types and Applications
 Table 12. Global Key Manufacturers of Codeine, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Codeine Companies by Tier (Tier 1, Tier 2, Tier 3), based on Codeine Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Codeine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Codeine Sales by Region (M Units), 2021–2026
 Table 18. Global Codeine Sales Market Share by Region (2021–2026)
 Table 19. Global Codeine Sales by Region (M Units), 2027–2032
 Table 20. Global Codeine Sales Market Share by Region (2027–2032)
 Table 21. Global Codeine Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Codeine Revenue Market Share by Region (2021–2026)
 Table 23. Global Codeine Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Codeine Revenue Market Share by Region (2027–2032)
 Table 25. North America Codeine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Codeine Sales by Country (M Units), 2021–2026
 Table 27. North America Codeine Sales by Country (M Units), 2027–2032
 Table 28. North America Codeine Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Codeine Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Codeine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Codeine Sales by Country (M Units), 2021–2026
 Table 32. Europe Codeine Sales by Country (M Units), 2027–2032
 Table 33. Europe Codeine Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Codeine Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Codeine Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Codeine Sales by Region (M Units), 2021–2026
 Table 37. Asia Pacific Codeine Sales by Region (M Units), 2027–2032
 Table 38. Asia Pacific Codeine Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Codeine Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Codeine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Codeine Sales by Country (M Units), 2021–2026
 Table 42. Latin America Codeine Sales by Country (M Units), 2027–2032
 Table 43. Latin America Codeine Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Codeine Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Codeine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Codeine Sales by Country (M Units), 2021–2026
 Table 47. Middle East and Africa Codeine Sales by Country (M Units), 2027–2032
 Table 48. Middle East and Africa Codeine Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Codeine Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Codeine Sales (M Units) by Ingredient (2021–2026)
 Table 51. Global Codeine Sales (M Units) by Ingredient (2027–2032)
 Table 52. Global Codeine Sales Market Share by Ingredient (2021–2026)
 Table 53. Global Codeine Sales Market Share by Ingredient (2027–2032)
 Table 54. Global Codeine Revenue (US$ Million) by Ingredient (2021–2026)
 Table 55. Global Codeine Revenue (US$ Million) by Ingredient (2027–2032)
 Table 56. Global Codeine Revenue Market Share by Ingredient (2021–2026)
 Table 57. Global Codeine Revenue Market Share by Ingredient (2027–2032)
 Table 58. Global Codeine Price (USD/Unit) by Ingredient (2021–2026)
 Table 59. Global Codeine Price (USD/Unit) by Ingredient (2027–2032)
 Table 60. Global Codeine Sales (M Units) by Application (2021–2026)
 Table 61. Global Codeine Sales (M Units) by Application (2027–2032)
 Table 62. Global Codeine Sales Market Share by Application (2021–2026)
 Table 63. Global Codeine Sales Market Share by Application (2027–2032)
 Table 64. Global Codeine Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Codeine Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Codeine Revenue Market Share by Application (2021–2026)
 Table 67. Global Codeine Revenue Market Share by Application (2027–2032)
 Table 68. Global Codeine Price (USD/Unit) by Application (2021–2026)
 Table 69. Global Codeine Price (USD/Unit) by Application (2027–2032)
 Table 70. Taiji Company Information
 Table 71. Taiji Description and Business Overview
 Table 72. Taiji Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 73. Taiji Codeine Product
 Table 74. Taiji Recent Developments/Updates
 Table 75. Mallinckrodt Company Information
 Table 76. Mallinckrodt Description and Business Overview
 Table 77. Mallinckrodt Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 78. Mallinckrodt Codeine Product
 Table 79. Mallinckrodt Recent Developments/Updates
 Table 80. TEVA Company Information
 Table 81. TEVA Description and Business Overview
 Table 82. TEVA Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 83. TEVA Codeine Product
 Table 84. TEVA Recent Developments/Updates
 Table 85. Johnson & Johnson Company Information
 Table 86. Johnson & Johnson Description and Business Overview
 Table 87. Johnson & Johnson Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 88. Johnson & Johnson Codeine Product
 Table 89. Johnson & Johnson Recent Developments/Updates
 Table 90. Medreich Company Information
 Table 91. Medreich Description and Business Overview
 Table 92. Medreich Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 93. Medreich Codeine Product
 Table 94. Medreich Recent Developments/Updates
 Table 95. Sanofi Aventis Company Information
 Table 96. Sanofi Aventis Description and Business Overview
 Table 97. Sanofi Aventis Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 98. Sanofi Aventis Codeine Product
 Table 99. Sanofi Aventis Recent Developments/Updates
 Table 100. Cipla Company Information
 Table 101. Cipla Description and Business Overview
 Table 102. Cipla Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 103. Cipla Codeine Product
 Table 104. Cipla Recent Developments/Updates
 Table 105. Hikma Company Information
 Table 106. Hikma Description and Business Overview
 Table 107. Hikma Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 108. Hikma Codeine Product
 Table 109. Hikma Recent Developments/Updates
 Table 110. Pharmaceutical Associates Company Information
 Table 111. Pharmaceutical Associates Description and Business Overview
 Table 112. Pharmaceutical Associates Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 113. Pharmaceutical Associates Codeine Product
 Table 114. Pharmaceutical Associates Recent Developments/Updates
 Table 115. Novartis Company Information
 Table 116. Novartis Description and Business Overview
 Table 117. Novartis Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 118. Novartis Codeine Product
 Table 119. Novartis Recent Developments/Updates
 Table 120. Apotex Company Information
 Table 121. Apotex Description and Business Overview
 Table 122. Apotex Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 123. Apotex Codeine Product
 Table 124. Apotex Recent Developments/Updates
 Table 125. Mylan Company Information
 Table 126. Mylan Description and Business Overview
 Table 127. Mylan Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 128. Mylan Codeine Product
 Table 129. Mylan Recent Developments/Updates
 Table 130. Aristo Pharma GmbH Company Information
 Table 131. Aristo Pharma GmbH Description and Business Overview
 Table 132. Aristo Pharma GmbH Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 133. Aristo Pharma GmbH Codeine Product
 Table 134. Aristo Pharma GmbH Recent Developments/Updates
 Table 135. Lannett Company Company Information
 Table 136. Lannett Company Description and Business Overview
 Table 137. Lannett Company Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 138. Lannett Company Codeine Product
 Table 139. Lannett Company Recent Developments/Updates
 Table 140. Laboratoire Riva Company Information
 Table 141. Laboratoire Riva Description and Business Overview
 Table 142. Laboratoire Riva Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 143. Laboratoire Riva Codeine Product
 Table 144. Laboratoire Riva Recent Developments/Updates
 Table 145. Key Raw Materials Lists
 Table 146. Raw Materials Key Suppliers Lists
 Table 147. Codeine Distributors List
 Table 148. Codeine Customers List
 Table 149. Codeine Market Trends
 Table 150. Codeine Market Drivers
 Table 151. Codeine Market Challenges
 Table 152. Codeine Market Restraints
 Table 153. Research Programs/Design for This Report
 Table 154. Key Data Information from Secondary Sources
 Table 155. Key Data Information from Primary Sources
 Table 156. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Codeine
 Figure 2. Global Codeine Market Value by Ingredient (US$ Million), 2021–2032
 Figure 3. Global Codeine Market Share by Ingredient: 2025 & 2032
 Figure 4. Single-ingredient Codeine Product Picture
 Figure 5. Multi-ingredient Medications Product Picture
 Figure 6. Global Codeine Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Codeine Market Share by Application: 2025 & 2032
 Figure 8. Narcotic Analgesic
 Figure 9. Antitussive
 Figure 10. Others
 Figure 11. Global Codeine Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 12. Global Codeine Market Size (US$ Million), 2021–2032
 Figure 13. Global Codeine Sales (M Units), 2021–2032
 Figure 14. Global Codeine Average Price (USD/Unit), 2021–2032
 Figure 15. Codeine Report Years Considered
 Figure 16. Codeine Sales Share by Manufacturers in 2025
 Figure 17. Global Codeine Revenue Share by Manufacturers in 2025
 Figure 18. Top 5 and Top 10 Global Codeine Players: Market Share by Revenue in Codeine in 2025
 Figure 19. Codeine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 20. Global Codeine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 21. North America Codeine Sales Market Share by Country (2021–2032)
 Figure 22. North America Codeine Revenue Market Share by Country (2021–2032)
 Figure 23. U.S. Codeine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 24. Canada Codeine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Europe Codeine Sales Market Share by Country (2021–2032)
 Figure 26. Europe Codeine Revenue Market Share by Country (2021–2032)
 Figure 27. Germany Codeine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. France Codeine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. U.K. Codeine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Italy Codeine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Russia Codeine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Asia Pacific Codeine Sales Market Share by Region (2021–2032)
 Figure 33. Asia Pacific Codeine Revenue Market Share by Region (2021–2032)
 Figure 34. China Codeine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Japan Codeine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. South Korea Codeine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. India Codeine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Australia Codeine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Taiwan Codeine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Indonesia Codeine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Thailand Codeine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Malaysia Codeine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Philippines Codeine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Latin America Codeine Sales Market Share by Country (2021–2032)
 Figure 45. Latin America Codeine Revenue Market Share by Country (2021–2032)
 Figure 46. Mexico Codeine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Brazil Codeine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Argentina Codeine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Middle East and Africa Codeine Sales Market Share by Country (2021–2032)
 Figure 50. Middle East and Africa Codeine Revenue Market Share by Country (2021–2032)
 Figure 51. Turkey Codeine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Saudi Arabia Codeine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. UAE Codeine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. Global Sales Market Share of Codeine by Ingredient (2021–2032)
 Figure 55. Global Revenue Market Share of Codeine by Ingredient (2021–2032)
 Figure 56. Global Codeine Price (USD/Unit) by Ingredient (2021–2032)
 Figure 57. Global Sales Market Share of Codeine by Application (2021–2032)
 Figure 58. Global Revenue Market Share of Codeine by Application (2021–2032)
 Figure 59. Global Codeine Price (USD/Unit) by Application (2021–2032)
 Figure 60. Codeine Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network